| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 153.13× | 153.13× | 338.28× | 291.65× | 291.77× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.74× | 0.73× | 0.55× | 1.74× | 3.24× | ||
| 0.20× | 0.20× | 0.17× | 0.23× | 0.22× | ||
| 1.84× | 1.84× | 1.06× | 35.70× | 2.66× | ||
| −0.67× | −0.67× | 2.71× | 2.14× | 4.90× |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 291.77 | 291.65 | 338.28 | 153.13 | 153.13 | |
| Working Capital Turnover | 3.24 | 1.74 | 0.55 | 0.73 | 0.74 | |
| Asset Turnover | 0.22 | 0.23 | 0.17 | 0.20 | 0.20 | |
| Cash Conversion (CFO/Net Income) | 2.66 | 35.70 | 1.06 | 1.84 | 1.84 | |
| CFO/EBITDA | 4.90 | 2.14 | 2.71 | -0.67 | -0.67 |